{"id":1635,"date":"2021-07-11T13:40:33","date_gmt":"2021-07-11T06:40:33","guid":{"rendered":"https:\/\/nucleusfarma.com\/en\/?p=1635"},"modified":"2021-07-28T17:23:43","modified_gmt":"2021-07-28T10:23:43","slug":"ramuan-alami-ini-diteliti-untuk-obat-terapi-covid-19-apa-hasilnya","status":"publish","type":"post","link":"https:\/\/nucleusfarma.com\/en\/ramuan-alami-ini-diteliti-untuk-obat-terapi-covid-19-apa-hasilnya\/","title":{"rendered":"Ramuan Alami Ini Diteliti untuk Obat Terapi COVID-19, Apa Hasilnya?"},"content":{"rendered":"<p><img loading=\"lazy\" class=\"size-medium wp-image-1275 alignleft\" src=\"https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1-300x200.jpg 300w, https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1-16x12.jpg 16w, https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1.jpg 600w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><strong>Jakarta<\/strong>\u00a0&#8211;\u00a0PT Natura Nuswantara Nirmala (Nucleus Farma) membuktikan efektivitas produk Onoiwa MX sebagai adjuvant standar pengobatan pasien COVID-19 pada tahap awal. Penelitian melibatkan Guru Besar bidang Farmakologi Bahan Alam Fakultas Farmasi Universitas Pancasila, Prof Syamsudin, M. Biomed, praktisi dokter spesialis paru yang menangani COVID-19, dr Lusi Nursilawati Syamsi, Sp.P. Chaidir Amin dari BPPT, dan ahli statistika Dr Nurita Andayani.<\/p>\n<p>&nbsp;<\/p>\n<p>Sumber :\u00a0<a href=\"https:\/\/health.detik.com\/berita-detikhealth\/d-5639453\/ramuan-alami-ini-diteliti-untuk-obat-terapi-covid-19-apa-hasilnya\">https:\/\/health.detik.com\/berita-detikhealth\/d-5639453\/ramuan-alami-ini-diteliti-untuk-obat-terapi-covid-19-apa-hasilnya<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jakarta\u00a0&#8211;\u00a0PT Natura Nuswantara Nirmala (Nucleus Farma) membuktikan efektivitas produk Onoiwa MX sebagai adjuvant standar pengobatan pasien COVID-19 pada tahap awal. Penelitian melibatkan Guru Besar bidang Farmakologi Bahan Alam Fakultas Farmasi Universitas Pancasila, Prof Syamsudin, M. Biomed, praktisi dokter spesialis paru yang menangani COVID-19, dr Lusi Nursilawati Syamsi, Sp.P. Chaidir Amin dari BPPT, dan ahli statistika [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":1275,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[9],"tags":[],"_links":{"self":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/1635"}],"collection":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/comments?post=1635"}],"version-history":[{"count":3,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/1635\/revisions"}],"predecessor-version":[{"id":1679,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/1635\/revisions\/1679"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/media\/1275"}],"wp:attachment":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/media?parent=1635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/categories?post=1635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/tags?post=1635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}